Table 5.
Outcomes and Complications
| Variables | N (%) |
|---|---|
| Clinical cure | 23/28 (82.1) |
| Etiological validity | 26/28 (92.9) |
| Time from application of polymyxin B to negative CSF culture (mean ± SD) (range), days | 8.23±4.02 (3–16) |
| Death | 5/28 (17.6) |
| SVH | 2/28 (7.1) |
| Extensive brain parenchymal infection | 2/28 (7.1) |
| Massive secondary cerebral infarction | 1/28 (3.6) |
| Complications | |
| Hydrocephalus | 18/28 (55.9) |
| VPS | 18/28 (55.9) |
| Time from negative CSF cultures to VPS (Median)(IQR), days | 82.5 (59.5,114.75) |
| Epilepsy | 0/28 (0.0) |
Abbreviations: SVH, spontaneous ventricular hemorrhage; VPS, ventriculoperitoneal shunt; CSF, cerebrospinal fluid.